Filing Details

Accession Number:
0001179110-14-012605
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-08-08 16:18:40
Reporting Period:
2014-08-08
Filing Date:
2014-08-08
Accepted Time:
2014-08-08 16:18:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1260990 Gtx Inc GTXI Pharmaceutical Preparations (2834) 621715807
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1276242 Patton Henry Doggrell 175 Toyota Plaza
7Th Floor
Memphis TN 38103
Vp, Chief Legal Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-08-08 10,000 $0.97 102,913 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,000 Indirect By IRA
Common Stock 6,641 Indirect By Spouse
Common Stock 2,177 Indirect By Trust
Common Stock 5,000 Indirect By Trust
Common Stock 2,177 Indirect By Trust
Footnotes
  1. An Aggregate of 10,000 shares of common stock were purchased in multiple trades on August 8, 2014 at prices ranging from $0.97 to $0.99. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, GTx, Inc. or a shareholder of GTx, Inc. full information regarding the number of shares and prices at which the transaction was effected.
  2. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for the purposes of Section 16 or any other purpose.